Product Segmentation:
*Coronary Artery Disease:* The market for drug-eluting balloon catheters used in the treatment of coronary artery disease is expected to witness steady growth due to the increasing prevalence of heart diseases and the growing adoption of minimally invasive procedures.
*Peripheral Vascular Disease:* The segment focusing on drug-eluting balloon catheters for peripheral vascular disease is likely to experience significant growth as the demand for advanced treatment options for conditions like peripheral artery disease continues to rise.
Raw Material Segmentation:
*Polyurethane:* Drug-eluting balloon catheters made from polyurethane are expected to dominate the market due to their favorable properties such as flexibility, durability, and biocompatibility.
*Nylon:* Nylon-based drug-eluting balloon catheters are also gaining traction in the market, driven by their strength, compatibility with different drugs, and ease of use.
*Others:* The segment encompassing drug-eluting balloon catheters made from other raw materials is anticipated to witness moderate growth, as manufacturers continue to explore new materials to enhance the performance of these devices.
End-Use Segmentation:
*Hospitals and Clinics:* Drug-eluting balloon catheters are primarily used in hospitals and clinics for various cardiovascular procedures, including coronary and peripheral interventions, contributing to the significant market share held by this segment.
*Catheterization Laboratories:* The increasing focus on catheter-based interventions and the rising number of catheterization laboratories globally are expected to drive the demand for drug-eluting balloon catheters in this segment, creating lucrative opportunities for market players.